Position Paper - Europabio

About us
- What we do
- Who we are
Members
- EuropaBio Members
- About Membership
How we work
Activities
News & Events
- News
- Events
Library

Become a member

24/12/2020

Joint Statement: Comitology Reform Threatens Innovation
30/11/2020

Call for more effective EU regulation of Clinical Trials with Advanced Therapy Medicinal Products consisting of or containing Genetically Modified Organisms
20/10/2020

EuropaBio on Use of Real-World Data (RWD) and Real-World Evidence (RWE) for regulatory decision-making
19/10/2020

Application of the ATMP Hospital Exemption in the EU
30/09/2020

EuropaBio Patient engagement with the European Medicines Agency
13/08/2020

Statement in response to the publication of the European Commission’s evaluation of the Orphan and Paediatric Regulations
03/08/2020

Joint Statement on the Health Innovation Partnership Proposal
30/07/2020

Joint response of EuropaBio and BIO on the EU Data Strategy Consultation
30/07/2020

EuropaBio response to the public consultation on the Roadmap for an EU Pharmaceutical Strategy
30/07/2020

EuropaBio response to the Work Programme of the eHealth Stakeholder Group
15/07/2020

EuropaBio position paper on the Farm to Fork Strategy
30/06/2020

EuropaBio observations in response to Europe’s Beating Cancer Plan
22/06/2020

EuropaBio position on the EU Biodiversity Strategy for 2030
19/06/2020

ACCELERATE FAIR Initiative Letter of Support
17/06/2020

EU-UK Future Relations – Joint Letter Life Sciences Coalition
26/05/2020

Joint statement on the EU Climate Law
20/05/2020

EuropaBio position on Germline Genome Editing
29/04/2020

European Bioeconomy Alliance (EUBA) Position on the EU Green Deal
10/04/2020

European Industry trade and supply chain needs to respond to Covid-19 – Joint Letter to the EU Trade Ministers
09/03/2020

EuropaBio Position & Policy Recommendations to support EU ATMP Innovation

1 2 3 4 5

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

Extra links

Newsroom

Become a member

Media pack

Become a member

Algal Omega 3

Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

Cheese

Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.

Clothes

Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

Vitamin B2

The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

Detergents

Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

Insulin

Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.